Last data update: May 13, 2024 . (Total: 1930 publications since 2020)
Records 1-2 (of 2 Records) |
Query Trace: Gubareva LV[original query] |
---|
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.
Govorkova EA , Takashita E , Daniels RS , Fujisaki S , Presser LD , Patel MC , Huang W , Lackenby A , Nguyen HT , Pereyaslov D , Rattigan A , Brown SK , Samaan M , Subbarao K , Wong S , Wang D , Webby RJ , Yen HL , Zhang W , Meijer A , Gubareva LV . Antiviral Res 2022 200 105281 |
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
Ison MG , Hayden FG , Hay AJ , Gubareva LV , Govorkova EA , Takashita E , McKimm-Breschkin JL . Antiviral Res 2021 194 105158 |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure